Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.58 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 3/20 | 0.44 |
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.44 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.44 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9732005 | 0.91 | TAAR1 (0.54) | TAAR1DRD2DRD3SLC6A2SLC6A3 | |
| SCHEMBL8671494 | 0.87 | TAAR1 (0.71) | TAAR1DRD2DRD3SLC6A2SLC6A3 | |
| SCHEMBL2089546 | 0.81 | CALM1 (0.57) | TAAR1DRD2DRD3SLC6A2SLC6A3 | |
| SCHEMBL12809383 | 0.78 | TSHR (0.48) | TAAR1DRD2DRD3SLC6A2SLC6A3 | |
| SCHEMBL1309778 | 0.78 | — | — | |
| Benzylamine SCHEMBL6665627 | 0.77 | LOXL2 (0.61) | TAAR1SLC6A2SLC6A3MAOBCYP2A6 | |
| Thiophene SCHEMBL10954809 | 0.77 | ALDH1A1 (0.57) | TAAR1MAOAMAOBCYP2A6ALDH1A1 | |
| SCHEMBL9855401 | 0.77 | TAAR1 (0.65) | TAAR1DRD2DRD3SLC6A2SLC6A3 | |
| SCHEMBL22476117 | 0.76 | MAOB (0.44) | TAAR1DRD2DRD3SLC6A2SLC6A3 | |
| SCHEMBL29021045 | 0.76 | DRD2 (0.47) | TAAR1DRD2DRD3SLC6A2SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009111337-A1 | COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS | IRM LLC (BM) | 2009-09-11 | — | — | WO | claimed |
| CN-117693545-A | Organosilicon polymer compound and organosilicon polymer material | 国立大学法人大阪大学 | 2024-03-12 | — | — | CN | disclosed |
| WO-2024028426-A1 | COMPOSITION | MERCK PATENT GMBH (DE) | 2024-02-08 | — | — | WO | disclosed |
| CN-111801355-B | Polymer material and method for producing same | 国立大学法人大阪大学 | 2023-02-28 | — | — | CN | disclosed |
| WO-2021045203-A1 | POLYMER MATERIAL AND PRODUCTION METHOD THEREFOR | 国立大学法人大阪大学 | 2021-03-11 | — | — | WO | disclosed |
| WO-2020216813-A1 | NANOPARTICLE | MERCK PATENT GMBH (DE) | 2020-10-29 | — | — | WO | disclosed |
| CN-111801355-A | Polymer material and method for producing same | 国立大学法人大阪大学 | 2020-10-20 | — | — | CN | disclosed |
| US-6613804-B2 | Treatment of hypertension, cardiovascular disease, pulmonary hypertension, erythropoietin-mediated vasoconstriction, endotoxin shock, pulmonary hypertension, anaphylactic shock and hemorrhagic shock | ENCYSIVE PHARMACEUTICALS, INC. | 2003-09-02 | — | — | US | disclosed |
| EP-0819125-B1 | THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORP (US) | 2003-06-18 | — | — | EP | disclosed |
| US-20020095041-A1 | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin | ENCYSIVE PHARMACEUTICALS INC. | 2002-07-18 | — | — | US | disclosed |
| EP-0870764-A1 | Sulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-10-14 | — | — | EP | disclosed |
| EP-0819125-A1 | THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-01-21 | — | — | EP | disclosed |
| US-5594021-A | VASOCONSTRICTORS | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5571821-A | CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-11-05 | — | — | US | disclosed |
| WO-1996031492-A1 | THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-10-10 | — | — | WO | disclosed |
| EP-0699191-A1 | SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994027979-A1 | SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | IMMUNOPHARMACEUTICS, INC. (US) | 1994-12-08 | — | — | WO | disclosed |
| CN-1035291-A | The preparation method of thiophenethers | HOECHST AG (DE) | 1989-09-06 | — | — | CN | disclosed |
| US-4711742-A | Solution processible forms of neutral and electrically conductive poly(substituted heterocycles) | ALLIED CORPORATION (US) | 1987-12-08 | — | — | US | disclosed |
| EP-0203438-A1 | Solution processible forms of neutral and electrically conductive poly(substituted heterocycles) | ALLIED CORPORATION (US) | 1986-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020095041-A1 | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin | EDNRB, EDNRA, ECE2 | TAAR1 1221/4885DRD2 2080/4885DRD3 3061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.